Abbott
$122.789876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$122.78
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.57 (+0.47%) Today
$0.00 (0.00%) As of 9:02 PM UTC after-hours
Why Robinhood?
You can buy or sell Abbott and other stocks, options, and ETFs commission-free!
About ABT
Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL. The listed name for ABT is Abbott Laboratories.
CEO
Robert B. Ford
Employees
109,000
Headquarters
Abbott Park, Illinois
Founded
1888
Market Cap
221.70B
Price-Earnings Ratio
47.83
Dividend Yield
1.28
Average Volume
5.07M
High Today
$123.08
Low Today
$121.19
Open Price
$122.76
Volume
4.83M
52 Week High
$128.54
52 Week Low
$61.61
ABT News
Analyst Ratings
80%
of 20 ratings
Buy
80%
Hold
10%
Sell
10%
ABT Earnings
$0.00
$0.48
$0.97
$1.45
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected Apr 14, Pre-Market